Data / Form D filings / SINGLE CELL TECHNOLOGY, INC.
SINGLE CELL TECHNOLOGY, INC.: Form D filings
SINGLE CELL TECHNOLOGY, INC., a biotechnology company in San Jose, CA, filed 3 Form D notices with the SEC between 2012 and 2021. The latest, on February 19, 2021, reports $2.1 million sold of a $2.1 million offering to 15 investors.
Find out what SINGLE CELL TECHNOLOGY, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6280 SAN IGNACIO AVE., SUITE E, San Jose, CA, 95119
- Phone
- (408) 642-9740
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1565042
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2021 | New notice | $2,146,924 | $2,135,559 | $11,365 | 15 | Jan 22, 2021 | sec.gov |
| Jul 25, 2013 | Amendment | $1,378,000 | $323,777 | $1,054,223 | 9 | Dec 12, 2012 | sec.gov |
| Dec 20, 2012 | New notice | $1,000,000 | $105,000 | $895,000 | 2 | Dec 12, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chun-Nan Chen | Executive Officer, Director | |
| James O Bowlby, Jr. | Director | |
| Richard O Jorgensen | Director | |
| Yen-Ming O Hsu | Director | |
| Jun O Tien | Director | |
| David O Sasseen | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Feb 15, 2021 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SINGLE CELL TECHNOLOGY, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.